Intended Use
This kit is intended for use as a point-of-care test to quantitatively measure the content of pepsinogen I (PG I) and pepsinogen II (PG II) in human samples (serum and plasma) in vitro. The test is suitable for the evaluation of the function of gastric acid secreting gland cells and gastric fundus mucinous gland lesions.